Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas
Clinical trial NCT01318642 · TERMINATED
Trial details
- NCT number
- NCT01318642
- Sponsor
- NantBioScience, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-31
- Primary completion
- 2012-11-27
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.